These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15529454)

  • 1. The antibiotic pipeline.
    Montgomery AB
    N Engl J Med; 2004 Nov; 351(19):2019-20. PubMed ID: 15529454
    [No Abstract]   [Full Text] [Related]  

  • 2. The National Institutes of Health Small Business Innovation Research (SBIR) Program: opportunities for orphan drug development.
    Engstrom LO
    Prog Clin Biol Res; 1985; 197():25-30. PubMed ID: 4070295
    [No Abstract]   [Full Text] [Related]  

  • 3. Orphan products development and some methods for maximizing the usefulness of research on rare diseases.
    Finkel MJ
    Prog Clin Biol Res; 1985; 197():11-8. PubMed ID: 4070285
    [No Abstract]   [Full Text] [Related]  

  • 4. The Orphan Products Board of the Department of Health & Human Services.
    Crooks GM
    Prog Clin Biol Res; 1985; 197():19-23. PubMed ID: 4070294
    [No Abstract]   [Full Text] [Related]  

  • 5. Improving antibiotic markets for long-term sustainability.
    Kesselheim AS; Outterson K
    Yale J Health Policy Law Ethics; 2011; 11(1):101-67. PubMed ID: 21381513
    [No Abstract]   [Full Text] [Related]  

  • 6. Should the patent system for new medicines be abolished?
    DiMasi JA; Grabowski HG
    Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100
    [No Abstract]   [Full Text] [Related]  

  • 7. Rare diseases, orphan drugs, and orphaned patients.
    Scheindlin S
    Mol Interv; 2006 Aug; 6(4):186-91. PubMed ID: 16960139
    [No Abstract]   [Full Text] [Related]  

  • 8. NIH gives money for orphan development.
    Watanabe ME
    Nat Med; 2000 Nov; 6(11):1197-8. PubMed ID: 11062512
    [No Abstract]   [Full Text] [Related]  

  • 9. The National Cancer Institute's Drug Development Program.
    Schepartz SA
    Prog Clin Biol Res; 1985; 197():73-82. PubMed ID: 4070301
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA's interferon-beta decision reignites orphan debate.
    Marshall A
    Nat Biotechnol; 1999 Apr; 17(4):324-5. PubMed ID: 10207871
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of voluntary disease organizations in research and development of orphan drugs.
    Horansky R
    Prog Clin Biol Res; 1985; 197():179-81. PubMed ID: 4070293
    [No Abstract]   [Full Text] [Related]  

  • 12. The design and development of therapeutic agents for neuromuscular diseases.
    Lewis NJ
    Prog Clin Biol Res; 1985; 197():105-10. PubMed ID: 4070284
    [No Abstract]   [Full Text] [Related]  

  • 13. Hints on preparing successful orphan drug designation requests.
    Buday PV
    Food Drug Law J; 1996; 51(1):75-84. PubMed ID: 11794354
    [No Abstract]   [Full Text] [Related]  

  • 14. Expanding the minority biomedical pipeline--the way foreward.
    Norris KC; Agodoa LY
    Ethn Dis; 2008; 18(2 Suppl 1):foreward. PubMed ID: 18615893
    [No Abstract]   [Full Text] [Related]  

  • 15. Drugs bill to rein in profits.
    Gershon D
    Nature; 1994 Mar; 368(6470):381. PubMed ID: 8133874
    [No Abstract]   [Full Text] [Related]  

  • 16. Understanding orphan drug regulations: an EU and U.S. comparative analysis.
    Grienenberger A
    J Biolaw Bus; 2004; 7(3):58-61. PubMed ID: 15460604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The loneliness of fighting a rare cancer.
    Dockser Marcus A
    Health Aff (Millwood); 2010; 29(1):203-6. PubMed ID: 20048378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoting, improving and accelerating the drug development and approval processes.
    Graul AI
    Drug News Perspect; 2007; 20(1):45-55. PubMed ID: 17332899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Orphan drugs].
    Kolár J; Chalabala M; Srámková H
    Ceska Slov Farm; 2001 Mar; 50(2):59-65. PubMed ID: 11288591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The National Institutes of Health pain consortium: index of pain-related information available from the NIH.
    National Institutes of Health
    J Pain Palliat Care Pharmacother; 2005; 19(2):79-84. PubMed ID: 16061468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.